Anja Böhnke

An Illegitimate microRNA Target Site within the 3′ UTR of <i>MDM4</i> Affects Ovarian Cancer Progression and Chemosensitivity

Jessika Wynendaele, Anja Böhnke, Eleonora Leucci et al. · Cancer Research · 2010 · 166 citations · Full text

Life Sciences, Genetics, Oncology +15

Significance of <i>HDMX</i>‐S (or <i>MDM4</i>) mRNA splice variant overexpression and <i>HDMX</i> gene amplification on primary soft tissue sarcoma prognosis

Frank Bartel, Jördis Schulz, Anja Böhnke et al. · International Journal of Cancer · 2005 · 91 citations · Full text

Medicine, Molecular Biology, Oncology +17

Both Germ Line and Somatic Genetics of the p53 Pathway Affect Ovarian Cancer Incidence and Survival

Frank Bartel, Juliane Jung, Anja Böhnke et al. · Clinical Cancer Research · 2008 · 67 citations

Medicine, Genetics, Oncology +15

Altered tumor formation and evolutionary selection of genetic variants in the human MDM4 oncogene

Gurinder S. Atwal, Tomas Kirchhoff, Elisabeth E. Bond et al. · Proceedings of the National Academy of Sciences · 2009 · 64 citations · Full text

Medicine, Genetics, Molecular Genetics +14

Role of p53 mutations, protein function and DNA damage for the radiosensitivity of human tumour cells

Anja Böhnke, Fritz Westphal, Alina Schmidt et al. · International Journal of Radiation Biology · 2004 · 56 citations

Medicine, Molecular Biology, Oncology +16